Triple-positive profile may flag adverse prostate cancer pathology
-
By
-
Andrea Surnit
-
September 8, 2026
-
4 min
By
Andrea Surnit
September 8, 2026
by Andrea Surnit
September 8, 2026
A randomized clinical trial found higher chronic GVHD-free survival and lower rates of serious chronic GVHD compared with standard transplantation in adults with blood cancers.
July 1, 2026
A splinter injury progressed to finger necrosis in a patient with MDS, despite antibacterial treatment and no clinically apparent systemic dissemination.
October 26, 2026
Phase 3 SURPASS ET data showed higher durable response rates with ropeginterferon alfa-2b-njft than with anagrelide.
September 1, 2026